Trial

Bristol Myers Squibb's Cobenfy Faces Setback in Schizophrenia Treatment

1 month ago

Bristol Myers Squibb (BMS) has encountered a significant hurdle as its experimental drug, Cobenfy, has reportedly failed to achieve its main goals in a crucial clinical trial aimed at treating schizophrenia. This unexpected development raises concerns about the potential for the drug to contribute positively to therapeutic options for patients struggling with this severe mental health disorder.

China's Alumina Exports Reach Seven-Year Peak Amid Expanding Surplus

2 months ago

In a remarkable shift, China's alumina exports have surged to their highest level in seven years, signaling a notable change in the global aluminium industry. This sharp increase can be attributed to excess production capacity within the country, which has set off a chain reaction in international trade dynamics.

Wells Fargo Appoints UBS Executive Moskal as Head of Industrial Sector

2 months ago

In a significant move within the financial services sector, Wells Fargo has announced the appointment of Andrew Moskal, a respected dealmaker from UBS, as the new chair of its industrials group. This strategic shift is seen as an effort to bolster the bank's presence and expertise in the industrial sector, which is vital for Wells Fargo's broad portfolio. Moskal's extensive experience, particularly in mergers and acquisitions within the industrial sector, is expected to lend valuable insights and leadership to the bank's operations.

EU Business Group Urges China to Revamp Its Industrial Strategy Amidst Global Trade Tensions

2 months ago

In a significant development regarding international trade relations, the European Union's business chamber has issued a strong recommendation for China to reform its industrial policies. This call to action reflects growing concerns among European businesses regarding the impact of China's current economic strategies on their market competitiveness.

China's Economic Growth Surpasses Expectations Ahead of Tariff Impact

2 months ago

In a surprising turn of events, China's economic growth for the first quarter of 2025 has outstripped analysts' forecasts, indicating resilience in the face of looming tariff changes. The nation has reported a growth rate of 5.2%, a robust figure considering the turbulence surrounding international trade relations and ongoing tariff negotiations, particularly with Western countries.

Sanofi’s Latest Asthma Drug Trial Yields Disappointing Results

2 months ago

In a significant setback for Sanofi, the pharmaceutical giant’s next-generation asthma medication, dubbed SNY-123, has failed to meet the efficacy benchmarks during its clinical trials, raising concerns about its potential in an already competitive market. This development has sent ripples through the biotech community, highlighting the uncertainties associated with drug development in the challenging field of respiratory medicine.

Verve Therapeutics Shares Surge Following Promising New Trial Results

2 months ago

Shares of Verve Therapeutics experienced a significant uptick after the company announced results from its latest clinical trial, which indicated no safety concerns associated with its innovative gene-editing therapy designed to treat cardiovascular diseases. The trial's successful outcomes have not only boosted investor confidence but also highlighted the growing potential of genetic treatments in the medical field.

Reviving America's Industry: The Federal Initiative for a New Golden Age

2 months ago

The United States is at the precipice of what many argue could be a new golden age in industrial development, but it’s going to take more than just market forces to realize this potential. A report has emphasized the crucial role that federal support will play in shaping a robust and sustainable industrial landscape. With the recent focus on rebuilding supply chains and bolstering domestic manufacturing, the Biden administration believes that strategic federal interventions can substantially inspire economic growth.

Hungary's Industrial Sector Faces Significant Decline Amidst Automotive and Battery Industry Struggles

2 months ago

Hungary's industrial sector is currently undergoing a notable downturn, witnessing its most severe contraction since the onset of 2023. This decline is primarily attributed to challenges faced within the automotive and battery manufacturing sectors, which are integral to the nation’s economy. Recent data indicates that industrial output dropped sharply in March, reflecting broader concerns about future growth prospects.

Roche's Leading Drug Faces Setback: High-Dose Version Fails Key Study

2 months ago

Roche Holding AG is grappling with unexpected turbulence as the high-dose variant of its blockbuster drug has failed to meet efficacy expectations in a critical clinical trial. This development comes as a significant blow to the Swiss pharmaceutical giant, which was banking on this new formulation to bolster its revenue streams.